Diagnostic Challenges of Lyme Neuroborreliosis in Inpatient Neurology: A Case Series
- PMID: 38895010
- PMCID: PMC11181985
- DOI: 10.1177/19418744241246308
Diagnostic Challenges of Lyme Neuroborreliosis in Inpatient Neurology: A Case Series
Abstract
Lyme disease is a multisystem disorder transmitted through the Ixodes tick and is most commonly diagnosed in northeastern and mid-Atlantic states, Wisconsin, and Minnesota, though its disease borders are expanding in the setting of climate change. Approximately 10%-15% of untreated Lyme disease cases will develop neurologic manifestations of Lyme neuroborreliosis (LNB). Due to varying presentations, LNB presents diagnostic challenges and is associated with a delay to treatment. We discuss three cases of LNB admitted to our referral center in a traditionally low-incidence state to highlight clinical pearls in LNB diagnosis. Three patients from low-incidence areas with prior diagnostic evaluations presented in August with neurologic manifestations of radiculoneuritis, cranial neuropathies, and/or lymphocytic meningitis. MRI findings included cranial nerve, nerve root, and leptomeningeal enhancement leading to broad differential diagnoses. Lumbar puncture demonstrated lymphocytic pleocytosis (range 85-753 cells/uL) and elevated protein (87-318 mg/dL). Each patient tested positive for Lyme on two-tiered serum testing and was diagnosed with LNB. All three cases were associated with a delay to health care presentation (mean 20 days) and a delay to diagnosis and treatment (mean 54 days) due to under-recognition and ongoing evaluation. With the geographic expansion of Lyme disease, increasing awareness of LNB manifestations and acquiring detailed travel histories in low-incidence areas is crucial to prompt delivery of care. Clinicians should be aware of two-tiered serum diagnostic requirements and use adjunctive studies such as lumbar puncture and MRI to eliminate other diagnoses. Treatment with an appropriate course of antibiotics leads to robust improvement in neurological symptoms.
Keywords: central nervous system bacterial infections; central nervous system infections; infectious disease medicine; neurohospitalist.
© The Author(s) 2024.
Conflict of interest statement
The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr Palmer has nothing to disclose. Dr Sokola has nothing to disclose. Dr Uysal has nothing to disclose. Dr Cooperrider has nothing to disclose. Dr Leung received an honorarium from the American Board of Internal Medicine on Longitudinal Knowledge Assessment Approval Committee. Dr Torres-Trejo has nothing to disclose. Dr Li served as a consultant for Advisory Board Meeting by Argenx, Catalyst, Immunovant, and UCB Pharma and received grant support from Argenx. Dr Abbatemarco: Served on scientific advisory boards for EMD Serono, Genentech, Horizon; Consulted with Alexion and received research support from Horizon.
Figures
References
-
- Surveillance Data | Lyme Disease | CDC, 2022. Accessed February 6, 2023. https://www.cdc.gov/lyme/datasurveillance/surveillance-data.html
LinkOut - more resources
Full Text Sources